Rohan is a seasoned product leader with 17 years of experience across a range of startups BharatPe Group, India’s leading name in the fintech ecosystem,...
The firm will now able to conduct research trials in the United States. The post Filament Health’s psychedelic drug candidate gains FDA nod appeared...
VANCOUVER, BC, Jan. 31, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage...
SAN FRANCISCO – Jaguar Health, Inc. (NASDAQ: JAGX) today announced that a preclinical study in mice initiated in Brazil by Magdalena Biosciences,...
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate...
MindBio Therapeutics Corp. announced it is nearing the completion of its Phase 2a clinical trial using MB22001 in patients with Major Depressive Disorder....
The company also named several other new executives. The post Huxley Health finalizes Sintalica deal, names Bruce Linton chairman appeared first on Green...
Privately-owned psychedelics company Huxley Health Inc. has completed its acquisition of Canadian drug discovery company Sintalica and named Bruce Linton...
Pulsed laser ablation in liquid (PLAL) is a reliable and versatile technique for producing metal nanoparticles (NPs) in solution. Its advantages, including...
Psychedelic Invest publishes its annual psychedelics industry report summarizing all of the events of 2023.